David Nayer

Washington, D.C., United States

Editor-in-Chief at Law Street

Content @DocketAlarm // editor @LawStreetMedia law, tech, history, media

Featured in: Favicon

lawstreetmedia.com Favicon

newsbreak.com

Articles

Questions About High-Flying Insulet Corp.

1 week ago | lawstreetmedia.com | David Nayer

FOIAengine: Multiple Hedge Funds Seeking Inspection ReportsLeading medical device manufacturer Insulet Corporation’s stock price (NASDAQ: PODD) is on a roll. But that hasn’t stopped leading financial firms from monitoring the company’s Food and Drug Administration plant inspections to learn of any bad news that might slow its growth.
Tourism Tumult: TPG Acquires Sabre’s Hospitality Solutions for $1.1B

2 weeks ago | lawstreetmedia.com | David Nayer

Alternative asset management firm TPG announced plans to acquire Sabre Corporation’s Hospitality Solutions business for $1.1 billion. The all-cash deal is projected to net Sabre $960 million, after accounting for taxes and fees, which will be used primarily to pay down debt. “Hospitality Solutions provides software and solutions to more than 40 percent of the world’s leading hotel brands,” according to the deal’s press release.
The History of Stockholder Suits, as Told by PACER

2 weeks ago | lawstreetmedia.com | David Nayer

In 1995, Congress passed the Private Securities Litigation Reform Act, or PSLRA. The law was designed to stem the tide of allegedly frivolous securities lawsuits. Such lawsuits are filed under Rule 10(b) of the Securities Exchange Act of 1934, and generally allege that the plaintiff’s investment holdings were devalued, via a decrease in stock price, by the misstatements or omissions of the defendant corporation. The PSLRA raises the pleading requirements for these lawsuits.
Latham and Covington Advise on Novartis’s Acquisition of Regulus

3 weeks ago | lawstreetmedia.com | David Nayer

Novartis announced plans to acquire Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company developing medicines targeting microRNAs, for $800 million. The all cash deal includes a contingent value right providing for an additional payment of $7.00 per share to Regulus shareholders, contingent upon the achievement of a milestone with respect to regulatory approval of the company’s farabursen product, which aims to treat autosomal dominant polycystic kidney disease.
The Crook, the Tycoon, the Short Seller, and Trump

3 weeks ago | lawstreetmedia.com | David Nayer

FOIAengine Tracks the High Cost of Getting Even, and the RewardsUntil six weeks ago, Jason Galanis was Inmate 80739-198 at the federal prison in Montgomery, Alabama, sentenced to almost 16 years confinement after admitting to a wild scheme in which he swindled tens of millions of dollars from the Oglala Sioux tribe and its pension fund.
As Autonomous Vehicles Hit the Road, Will Litigation Pile Up?

1 month ago | lawstreetmedia.com | David Nayer

After years of speculation and anticipation, self-driving cars can now be spotted on the roads in many American cities. One of the pioneers in the space, Waymo, operates its robotaxi service in cities like Phoenix and San Francisco, and is piloting its service in Washington, D.C.Self-driving cars pose novel and interesting questions for litigators – who is at fault when a self-driving car causes an accident, if there is no driver?
Billion-Dollar Shakedown: As Trump Punishes Big Law, Project 2025 Follows Up

1 month ago | lawstreetmedia.com | David Nayer

FOIAengine: Heritage’s Oversight Project Probes Law Firm Ties to BidenAmid President Trump’s recent high-profile efforts to punish or extract concessions from major law firms, a second front, much less publicized, has opened, with organizers of Project 2025 using the Freedom of Information Act to track prior contacts between at least two dozen major law firms and former Biden Administration officials.
Through the Stratosphere: Tinicum Acquires Leggett & Platt’s Aerospace Products

1 month ago | lawstreetmedia.com | David Nayer

Just in time for Katy Perry’s return to earth, Leggett & Platt announced plans to sell its Aerospace Products Group to affiliated funds managed by Tinicum Incorporated for $285 million. The all-cash deal is expected to close later this year, and is subject to customary regulatory approvals as well as working capital and debt adjustments.
Hedge Fund Point72 Targets J&J Cancer Drug

1 month ago | lawstreetmedia.com | David Nayer

FOIAengine: Questions Seek Adverse Reports about CarvyktiAccording to a new PoliScio Analytics analysis of early 2025 Freedom of Information Act requests, investment firm Point72 has launched a significant FOIA-driven investigation into Johnson & Johnson’s popular cancer drug Carvykti. According to Johnson & Johnson’s SEC filings and press releases, Carvykti has contributed significantly to the company’s recent financial performance and has benefitted hundreds of multiple myeloma patients.
False Claims Act Cases on the Rise Since Pandemic, Docket Alarm Data Suggests

1 month ago | lawstreetmedia.com | David Nayer

The False Claims Act (FCA) is a statute that allows for the federal government to recover damages when it has been defrauded. The law primarily targets cases involving knowingly false or fraudulent claims for payment submitted to the federal government or federally funded programs,with healthcare fraud, defense contractor fraud, and education fraud being common categories.